entertainment -WSS

entertainment

author：leisure time 2025-10-01 02:15:41 - browse：97

As a new class of diabetes and obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients. A new analysis of claims data from Trilliant Health suggests that collectively, telehealth companies — in particular, cash-pay options that market directly to consumers — could account for many of the patients with insurance claims for GLP-1 prescriptions in 2022.

Direct-to-consumer telehealth companies have offered an easier on-ramp for many patients to access prescriptions for a variety of conditions. And since the first GLP-1s were approved for obesity — promising up to 15% weight loss — many of those companies have capitalized on the approvals and surging demand to launch new weight loss businesses. Companies including Calibrate and Ro claim to have reached tens and hundreds of thousands of patients with their weight loss medication programs.

Collectively, their reach may be even larger. The Trilliant Health analysis, conducted on behalf of STAT, offers an early glimpse of the foothold those businesses have gained in GLP-1 prescribing. In a nationwide claims database of more than 300 million patients using both commercial and federal insurance, Trilliant Health found about 3.6 million people with a prescription claim for a GLP-1 — semaglutide, tirzepatide, or injectable liraglutide without insulin — in 2022. To determine where each patient may have gotten those prescriptions, they looked for a medical visit claim within three days of a prescription claim for a GLP-1 — the visit where the script was likely written. But they only found a matching visit for 53% of patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Sanofi CEO defends move to abandon profit guidance, boost research

explore

leisure time

WSS

Doctors are clamoring for more clarity on Paxlovid prescribing

FDA approves potent Eli Lilly obesity drug, Zepbound

Judge in Trump's classified documents case questions use of out

Doctors push to include dialysis machines in emergency stockpile

Senate panel clears PBM, hopsital reforms

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

explore

entertainment

Wikipedia

In age of alternative facts, a scholarly course on calling out crap

UCSF medical school apologizes for unethical prisoner experiments

Virginia high school admissions case could be legal follow

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

What does generative AI mean for health care? We asked experts

Tuberculosis patients need more than just free medication

Apple is now the first public company to be valued at $3 trillion

10 million people disenrolled from Medicaid over past six months

The cancer drug shortage isn’t new — and neither are the solutions

Judge in Trump's classified documents case questions use of out

focus

Extreme heat events are a public health emergency

Medicare will require more price transparency from hospitals

Kansas bar where gunfire wounded 9 last month closes permanently

Feed a cold, starve a fever? Here’s what science says

Victims of gun violence feel impacts long after bullet wound

Restaurant meals are packed with calories, and we still keep eating them

explore

entertainment

leisure time

focus